Search Result "complete hematologic remission (CHR)"
Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Journal: Current Drug Targets
Volume: 8 Issue: 2 Year: 2007 Page: 217-235
Author(s): M. A. Morgan, A. Ganser, C. W. M. Reuter
Interferon alpha for Treatment of Chronic Myeloid Leukemia
Journal: Current Drug Targets
Volume: 12 Issue: 3 Year: 2011 Page: 420-428
Author(s): Bengt Simonsson, Henrik Hjorth-Hansen, Ole Weis Bjerrum, Kimmo Porkka
Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 21-28
Author(s): Massimo Breccia, Giuliana Alimena
Evaluating Treatment Response of Chronic Myeloid Leukemia: Emerging Science and Technology
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 7 Year: 2013 Page: 779-790
Author(s): Antonia Cagnetta, Anna Garuti, Carlo Marani, Michele Cea, Maurizio Miglino, Ilaria Rocco, Claudia Palermo, Giuseppina Fugazza, Gabriella Cirmena, Nicoletta Colombo, Raffaella Grasso, Alessio Nencioni, Marco Gobbi, Franco Patrone
Chronic Myelogenous Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 3-13
Author(s): Robert P. Hasserjian
Current Treatment Concepts of CML
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 31-43
Author(s): A. A. Leitner, A. Hochhaus, M. C. Muller
Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL
Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 530-536
Author(s): Massimo Breccia, Giuliana Alimena
Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 7 Year: 2013 Page: 755-767
Author(s):
Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
Journal: Current Drug Targets
Volume: 12 Issue: 3 Year: 2011 Page: 392-419
Author(s): Hans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, Morten Krogh Jensen, Jean-Jacques Kiladjian
The Role of the Tyrosine Kinase Inhibitor STI571 in the Treatment of Cancer
Journal: Current Cancer Drug Targets
Volume: 1 Issue: 1 Year: 2001 Page: 49-57
Author(s): Michael E. ODwyer, Brian J. Druker